InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Browse the complete record of transactions filed by Breedlove Mark H., Director. Officer active across 1 company, notably Cognition Therapeutics INC. Aggregated, 1 filings have been recorded. Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration
Mark H. Breedlove is a Director at Cognition Therapeutics Inc. In this role, he participates in the governance of the company and contributes to strategic decision-making. His experience in the healthcare sector is valuable in guiding the company's initiatives.